[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2018-2023 Global Prostacyclin Consumption Market Report

September 2018 | 135 pages | ID: 2992F50E7A5EN
LP Information

US$ 4,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Prostacyclin market for 2018-2023.

Prostacyclin (also called prostaglandin I2 or PGI2) is a prostaglandin member of the eicosanoid family of lipid molecules. It inhibits platelet activation and is also an effective vasodilator.

Pulmonary arterial hypertension (PAH) is a chronic, life-threatening disorder characterized by abnormally high blood pressure in the arteries between the heart and lungs.

And in our report of prostacyclin, the “prostacyclin” means the drugs used for the treatment of pulmonary arterial hypertension.
Prostacyclin (also called prostaglandin I2 or PGI2) is a prostaglandin member of the eicosanoid family of lipid molecules. It inhibits platelet activation and is also an effective vasodilator.
The global average price of Prostacyclin is in the decreasing trend, from 60.2 USD/Unit in 2013 to 48.4 USD/Unit in 2017. With the situation of global economy, prices will be in decreasing trend in the following five years.
Prostacyclin is widely used for injection, for oral and for inhalation. The most proportion of Prostacyclin is used for oral, and the proportion in 2017 is about 55%. The trend of prostacyclin used for oral is increasing in the following years.
Over the next five years, LPI(LP Information) projects that Prostacyclin will register a 5.5% CAGR in terms of revenue, reach US$ 2420 million by 2023, from US$ 1760 million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Prostacyclin market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:
  • Epoprostenol Sodium
  • Treprostinil
  • Iloprost
  • Beraprost Sodium
Segmentation by application:
  • For Injection
  • For Oral
  • For Inhalation
This report also splits the market by region:
  • Americas
  • United States
  • Canada
  • Mexico
  • Brazil
  • APAC
  • China
  • Japan
  • Korea
  • Southeast Asia
  • India
  • Australia
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
  • Spain
  • Middle East & Africa
  • Egypt
  • South Africa
  • Israel
  • Turkey
  • GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
  • United Therapeutics
  • Actelion (J & J)
  • GSK
  • Teva
  • Toray
  • Tide Pharma
  • Bayer AG
  • ...
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
  • To study and analyze the global Prostacyclin consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
  • To understand the structure of Prostacyclin market by identifying its various subsegments.
  • Focuses on the key global Prostacyclin manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
  • To analyze the Prostacyclin with respect to individual growth trends, future prospects, and their contribution to the total market.
  • To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
  • To project the consumption of Prostacyclin submarkets, with respect to key regions (along with their respective key countries).
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
  • To strategically profile the key players and comprehensively analyze their growth strategies.
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Prostacyclin Consumption 2013-2023
  2.1.2 Prostacyclin Consumption CAGR by Region
2.2 Prostacyclin Segment by Type
  2.2.1 Epoprostenol Sodium
  2.2.2 Treprostinil
  2.2.3 Iloprost
  2.2.4 Beraprost Sodium
2.3 Prostacyclin Consumption by Type
  2.3.1 Global Prostacyclin Consumption Market Share by Type (2013-2018)
  2.3.2 Global Prostacyclin Revenue and Market Share by Type (2013-2018)
  2.3.3 Global Prostacyclin Sale Price by Type (2013-2018)
2.4 Prostacyclin Segment by Application
  2.4.1 For Injection
  2.4.2 For Oral
  2.4.3 For Inhalation
2.5 Prostacyclin Consumption by Application
  2.5.1 Global Prostacyclin Consumption Market Share by Application (2013-2018)
  2.5.2 Global Prostacyclin Value and Market Share by Application (2013-2018)
  2.5.3 Global Prostacyclin Sale Price by Application (2013-2018)

3 GLOBAL PROSTACYCLIN BY PLAYERS

3.1 Global Prostacyclin Sales Market Share by Players
  3.1.1 Global Prostacyclin Sales by Players (2016-2018)
  3.1.2 Global Prostacyclin Sales Market Share by Players (2016-2018)
3.2 Global Prostacyclin Revenue Market Share by Players
  3.2.1 Global Prostacyclin Revenue by Players (2016-2018)
  3.2.2 Global Prostacyclin Revenue Market Share by Players (2016-2018)
3.3 Global Prostacyclin Sale Price by Players
3.4 Global Prostacyclin Manufacturing Base Distribution, Sales Area, Product Types by Players
  3.4.1 Global Prostacyclin Manufacturing Base Distribution and Sales Area by Players
  3.4.2 Players Prostacyclin Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 PROSTACYCLIN BY REGIONS

4.1 Prostacyclin by Regions
  4.1.1 Global Prostacyclin Consumption by Regions
  4.1.2 Global Prostacyclin Value by Regions
4.2 Americas Prostacyclin Consumption Growth
4.3 APAC Prostacyclin Consumption Growth
4.4 Europe Prostacyclin Consumption Growth
4.5 Middle East & Africa Prostacyclin Consumption Growth

5 AMERICAS

5.1 Americas Prostacyclin Consumption by Countries
  5.1.1 Americas Prostacyclin Consumption by Countries (2013-2018)
  5.1.2 Americas Prostacyclin Value by Countries (2013-2018)
5.2 Americas Prostacyclin Consumption by Type
5.3 Americas Prostacyclin Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Prostacyclin Consumption by Countries
  6.1.1 APAC Prostacyclin Consumption by Countries (2013-2018)
  6.1.2 APAC Prostacyclin Value by Countries (2013-2018)
6.2 APAC Prostacyclin Consumption by Type
6.3 APAC Prostacyclin Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Prostacyclin by Countries
  7.1.1 Europe Prostacyclin Consumption by Countries (2013-2018)
  7.1.2 Europe Prostacyclin Value by Countries (2013-2018)
7.2 Europe Prostacyclin Consumption by Type
7.3 Europe Prostacyclin Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Prostacyclin by Countries
  8.1.1 Middle East & Africa Prostacyclin Consumption by Countries (2013-2018)
  8.1.2 Middle East & Africa Prostacyclin Value by Countries (2013-2018)
8.2 Middle East & Africa Prostacyclin Consumption by Type
8.3 Middle East & Africa Prostacyclin Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 MARKETING, DISTRIBUTORS AND CUSTOMER

10.1 Sales Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
10.2 Prostacyclin Distributors
10.3 Prostacyclin Customer

11 GLOBAL PROSTACYCLIN MARKET FORECAST

11.1 Global Prostacyclin Consumption Forecast (2018-2023)
11.2 Global Prostacyclin Forecast by Regions
  11.2.1 Global Prostacyclin Forecast by Regions (2018-2023)
  11.2.2 Global Prostacyclin Value Forecast by Regions (2018-2023)
  11.2.3 Americas Consumption Forecast
  11.2.4 APAC Consumption Forecast
  11.2.5 Europe Consumption Forecast
  11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
  11.3.1 United States Market Forecast
  11.3.2 Canada Market Forecast
  11.3.3 Mexico Market Forecast
  11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
  11.4.1 China Market Forecast
  11.4.2 Japan Market Forecast
  11.4.3 Korea Market Forecast
  11.4.4 Southeast Asia Market Forecast
  11.4.5 India Market Forecast
  11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
  11.5.1 Germany Market Forecast
  11.5.2 France Market Forecast
  11.5.3 UK Market Forecast
  11.5.4 Italy Market Forecast
  11.5.5 Russia Market Forecast
  11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
  11.6.1 Egypt Market Forecast
  11.6.2 South Africa Market Forecast
  11.6.3 Israel Market Forecast
  11.6.4 Turkey Market Forecast
  11.6.5 GCC Countries Market Forecast
11.7 Global Prostacyclin Forecast by Type
11.8 Global Prostacyclin Forecast by Application

12 KEY PLAYERS ANALYSIS

12.1 United Therapeutics
  12.1.1 Company Details
  12.1.2 Prostacyclin Product Offered
  12.1.3 United Therapeutics Prostacyclin Sales, Revenue, Price and Gross Margin (2016-2018)
  12.1.4 Main Business Overview
  12.1.5 United Therapeutics News
12.2 Actelion (J & J)
  12.2.1 Company Details
  12.2.2 Prostacyclin Product Offered
  12.2.3 Actelion (J & J) Prostacyclin Sales, Revenue, Price and Gross Margin (2016-2018)
  12.2.4 Main Business Overview
  12.2.5 Actelion (J & J) News
12.3 GSK
  12.3.1 Company Details
  12.3.2 Prostacyclin Product Offered
  12.3.3 GSK Prostacyclin Sales, Revenue, Price and Gross Margin (2016-2018)
  12.3.4 Main Business Overview
  12.3.5 GSK News
12.4 Teva
  12.4.1 Company Details
  12.4.2 Prostacyclin Product Offered
  12.4.3 Teva Prostacyclin Sales, Revenue, Price and Gross Margin (2016-2018)
  12.4.4 Main Business Overview
  12.4.5 Teva News
12.5 Toray
  12.5.1 Company Details
  12.5.2 Prostacyclin Product Offered
  12.5.3 Toray Prostacyclin Sales, Revenue, Price and Gross Margin (2016-2018)
  12.5.4 Main Business Overview
  12.5.5 Toray News
12.6 Tide Pharma
  12.6.1 Company Details
  12.6.2 Prostacyclin Product Offered
  12.6.3 Tide Pharma Prostacyclin Sales, Revenue, Price and Gross Margin (2016-2018)
  12.6.4 Main Business Overview
  12.6.5 Tide Pharma News
12.7 Bayer AG
  12.7.1 Company Details
  12.7.2 Prostacyclin Product Offered
  12.7.3 Bayer AG Prostacyclin Sales, Revenue, Price and Gross Margin (2016-2018)
  12.7.4 Main Business Overview
  12.7.5 Bayer AG News

...

13 RESEARCH FINDINGS AND CONCLUSION

LIST OF TABLES AND FIGURES

Figure Picture of Prostacyclin
Table Product Specifications of Prostacyclin
Figure Prostacyclin Report Years Considered
Figure Market Research Methodology
Figure Global Prostacyclin Consumption Growth Rate 2013-2023 (K Units)
Figure Global Prostacyclin Value Growth Rate 2013-2023 ($ Millions)
Table Prostacyclin Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of Epoprostenol Sodium
Table Major Players of Epoprostenol Sodium
Figure Product Picture of Treprostinil
Table Major Players of Treprostinil
Figure Product Picture of Iloprost
Table Major Players of Iloprost
Figure Product Picture of Beraprost Sodium
Table Major Players of Beraprost Sodium
Table Global Consumption Sales by Type (2013-2018)
Table Global Prostacyclin Consumption Market Share by Type (2013-2018)
Figure Global Prostacyclin Consumption Market Share by Type (2013-2018)
Table Global Prostacyclin Revenue by Type (2013-2018) ($ million)
Table Global Prostacyclin Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Prostacyclin Value Market Share by Type (2013-2018)
Table Global Prostacyclin Sale Price by Type (2013-2018)
Figure Prostacyclin Consumed in For Injection
Figure Global Prostacyclin Market: For Injection (2013-2018) (K Units)
Figure Global Prostacyclin Market: For Injection (2013-2018) ($ Millions)
Figure Global For Injection YoY Growth ($ Millions)
Figure Prostacyclin Consumed in For Oral
Figure Global Prostacyclin Market: For Oral (2013-2018) (K Units)
Figure Global Prostacyclin Market: For Oral (2013-2018) ($ Millions)
Figure Global For Oral YoY Growth ($ Millions)
Figure Prostacyclin Consumed in For Inhalation
Figure Global Prostacyclin Market: For Inhalation (2013-2018) (K Units)
Figure Global Prostacyclin Market: For Inhalation (2013-2018) ($ Millions)
Figure Global For Inhalation YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Prostacyclin Consumption Market Share by Application (2013-2018)
Figure Global Prostacyclin Consumption Market Share by Application (2013-2018)
Table Global Prostacyclin Value by Application (2013-2018)
Table Global Prostacyclin Value Market Share by Application (2013-2018)
Figure Global Prostacyclin Value Market Share by Application (2013-2018)
Table Global Prostacyclin Sale Price by Application (2013-2018)
Table Global Prostacyclin Sales by Players (2016-2018) (K Units)
Table Global Prostacyclin Sales Market Share by Players (2016-2018)
Figure Global Prostacyclin Sales Market Share by Players in 2016
Figure Global Prostacyclin Sales Market Share by Players in 2017
Table Global Prostacyclin Revenue by Players (2016-2018) ($ Millions)
Table Global Prostacyclin Revenue Market Share by Players (2016-2018)
Figure Global Prostacyclin Revenue Market Share by Players in 2016
Figure Global Prostacyclin Revenue Market Share by Players in 2017
Table Global Prostacyclin Sale Price by Players (2016-2018)
Figure Global Prostacyclin Sale Price by Players in 2017
Table Global Prostacyclin Manufacturing Base Distribution and Sales Area by Players
Table Players Prostacyclin Products Offered
Table Prostacyclin Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Prostacyclin Consumption by Regions 2013-2018 (K Units)
Table Global Prostacyclin Consumption Market Share by Regions 2013-2018
Figure Global Prostacyclin Consumption Market Share by Regions 2013-2018
Table Global Prostacyclin Value by Regions 2013-2018 ($ Millions)
Table Global Prostacyclin Value Market Share by Regions 2013-2018
Figure Global Prostacyclin Value Market Share by Regions 2013-2018
Figure Americas Prostacyclin Consumption 2013-2018 (K Units)
Figure Americas Prostacyclin Value 2013-2018 ($ Millions)
Figure APAC Prostacyclin Consumption 2013-2018 (K Units)
Figure APAC Prostacyclin Value 2013-2018 ($ Millions)
Figure Europe Prostacyclin Consumption 2013-2018 (K Units)
Figure Europe Prostacyclin Value 2013-2018 ($ Millions)
Figure Middle East & Africa Prostacyclin Consumption 2013-2018 (K Units)
Figure Middle East & Africa Prostacyclin Value 2013-2018 ($ Millions)
Table Americas Prostacyclin Consumption by Countries (2013-2018) (K Units)
Table Americas Prostacyclin Consumption Market Share by Countries (2013-2018)
Figure Americas Prostacyclin Consumption Market Share by Countries in 2017
Table Americas Prostacyclin Value by Countries (2013-2018) ($ Millions)
Table Americas Prostacyclin Value Market Share by Countries (2013-2018)
Figure Americas Prostacyclin Value Market Share by Countries in 2017
Table Americas Prostacyclin Consumption by Type (2013-2018) (K Units)
Table Americas Prostacyclin Consumption Market Share by Type (2013-2018)
Figure Americas Prostacyclin Consumption Market Share by Type in 2017
Table Americas Prostacyclin Consumption by Application (2013-2018) (K Units)
Table Americas Prostacyclin Consumption Market Share by Application (2013-2018)
Figure Americas Prostacyclin Consumption Market Share by Application in 2017
Figure United States Prostacyclin Consumption Growth 2013-2018 (K Units)
Figure United States Prostacyclin Value Growth 2013-2018 ($ Millions)
Figure Canada Prostacyclin Consumption Growth 2013-2018 (K Units)
Figure Canada Prostacyclin Value Growth 2013-2018 ($ Millions)
Figure Mexico Prostacyclin Consumption Growth 2013-2018 (K Units)
Figure Mexico Prostacyclin Value Growth 2013-2018 ($ Millions)
Table APAC Prostacyclin Consumption by Countries (2013-2018) (K Units)
Table APAC Prostacyclin Consumption Market Share by Countries (2013-2018)
Figure APAC Prostacyclin Consumption Market Share by Countries in 2017
Table APAC Prostacyclin Value by Countries (2013-2018) ($ Millions)
Table APAC Prostacyclin Value Market Share by Countries (2013-2018)
Figure APAC Prostacyclin Value Market Share by Countries in 2017
Table APAC Prostacyclin Consumption by Type (2013-2018) (K Units)
Table APAC Prostacyclin Consumption Market Share by Type (2013-2018)
Figure APAC Prostacyclin Consumption Market Share by Type in 2017
Table APAC Prostacyclin Consumption by Application (2013-2018) (K Units)
Table APAC Prostacyclin Consumption Market Share by Application (2013-2018)
Figure APAC Prostacyclin Consumption Market Share by Application in 2017
Figure China Prostacyclin Consumption Growth 2013-2018 (K Units)
Figure China Prostacyclin Value Growth 2013-2018 ($ Millions)
Figure Japan Prostacyclin Consumption Growth 2013-2018 (K Units)
Figure Japan Prostacyclin Value Growth 2013-2018 ($ Millions)
Figure Korea Prostacyclin Consumption Growth 2013-2018 (K Units)
Figure Korea Prostacyclin Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Prostacyclin Consumption Growth 2013-2018 (K Units)
Figure Southeast Asia Prostacyclin Value Growth 2013-2018 ($ Millions)
Figure India Prostacyclin Consumption Growth 2013-2018 (K Units)
Figure India Prostacyclin Value Growth 2013-2018 ($ Millions)
Figure Australia Prostacyclin Consumption Growth 2013-2018 (K Units)
Figure Australia Prostacyclin Value Growth 2013-2018 ($ Millions)
Table Europe Prostacyclin Consumption by Countries (2013-2018) (K Units)
Table Europe Prostacyclin Consumption Market Share by Countries (2013-2018)
Figure Europe Prostacyclin Consumption Market Share by Countries in 2017
Table Europe Prostacyclin Value by Countries (2013-2018) ($ Millions)
Table Europe Prostacyclin Value Market Share by Countries (2013-2018)
Figure Europe Prostacyclin Value Market Share by Countries in 2017
Table Europe Prostacyclin Consumption by Type (2013-2018) (K Units)
Table Europe Prostacyclin Consumption Market Share by Type (2013-2018)
Figure Europe Prostacyclin Consumption Market Share by Type in 2017
Table Europe Prostacyclin Consumption by Application (2013-2018) (K Units)
Table Europe Prostacyclin Consumption Market Share by Application (2013-2018)
Figure Europe Prostacyclin Consumption Market Share by Application in 2017
Figure Germany Prostacyclin Consumption Growth 2013-2018 (K Units)
Figure Germany Prostacyclin Value Growth 2013-2018 ($ Millions)
Figure France Prostacyclin Consumption Growth 2013-2018 (K Units)
Figure France Prostacyclin Value Growth 2013-2018 ($ Millions)
Figure UK Prostacyclin Consumption Growth 2013-2018 (K Units)
Figure UK Prostacyclin Value Growth 2013-2018 ($ Millions)
Figure Italy Prostacyclin Consumption Growth 2013-2018 (K Units)
Figure Italy Prostacyclin Value Growth 2013-2018 ($ Millions)
Figure Russia Prostacyclin Consumption Growth 2013-2018 (K Units)
Figure Russia Prostacyclin Value Growth 2013-2018 ($ Millions)
Figure Spain Prostacyclin Consumption Growth 2013-2018 (K Units)
Figure Spain Prostacyclin Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Prostacyclin Consumption by Countries (2013-2018) (K Units)
Table Middle East & Africa Prostacyclin Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Prostacyclin Consumption Market Share by Countries in 2017
Table Middle East & Africa Prostacyclin Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Prostacyclin Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Prostacyclin Value Market Share by Countries in 2017
Table Middle East & Africa Prostacyclin Consumption by Type (2013-2018) (K Units)
Table Middle East & Africa Prostacyclin Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Prostacyclin Consumption Market Share by Type in 2017
Table Middle East & Africa Prostacyclin Consumption by Application (2013-2018) (K Units)
Table Middle East & Africa Prostacyclin Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Prostacyclin Consumption Market Share by Application in 2017
Figure Egypt Prostacyclin Consumption Growth 2013-2018 (K Units)
Figure Egypt Prostacyclin Value Growth 2013-2018 ($ Millions)
Figure South Africa Prostacyclin Consumption Growth 2013-2018 (K Units)
Figure South Africa Prostacyclin Value Growth 2013-2018 ($ Millions)
Figure Israel Prostacyclin Consumption Growth 2013-2018 (K Units)
Figure Israel Prostacyclin Value Growth 2013-2018 ($ Millions)
Figure Turkey Prostacyclin Consumption Growth 2013-2018 (K Units)
Figure Turkey Prostacyclin Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Prostacyclin Consumption Growth 2013-2018 (K Units)
Figure GCC Countries Prostacyclin Value Growth 2013-2018 ($ Millions)
Table Prostacyclin Distributors List
Table Prostacyclin Customer List
Figure Global Prostacyclin Consumption Growth Rate Forecast (2018-2023) (K Units)
Figure Global Prostacyclin Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Prostacyclin Consumption Forecast by Countries (2018-2023) (K Units)
Table Global Prostacyclin Consumption Market Forecast by Regions
Table Global Prostacyclin Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Prostacyclin Value Market Share Forecast by Regions
Figure Americas Prostacyclin Consumption 2018-2023 (K Units)
Figure Americas Prostacyclin Value 2018-2023 ($ Millions)
Figure APAC Prostacyclin Consumption 2018-2023 (K Units)
Figure APAC Prostacyclin Value 2018-2023 ($ Millions)
Figure Europe Prostacyclin Consumption 2018-2023 (K Units)
Figure Europe Prostacyclin Value 2018-2023 ($ Millions)
Figure Middle East & Africa Prostacyclin Consumption 2018-2023 (K Units)
Figure Middle East & Africa Prostacyclin Value 2018-2023 ($ Millions)
Figure United States Prostacyclin Consumption 2018-2023 (K Units)
Figure United States Prostacyclin Value 2018-2023 ($ Millions)
Figure Canada Prostacyclin Consumption 2018-2023 (K Units)
Figure Canada Prostacyclin Value 2018-2023 ($ Millions)
Figure Mexico Prostacyclin Consumption 2018-2023 (K Units)
Figure Mexico Prostacyclin Value 2018-2023 ($ Millions)
Figure Brazil Prostacyclin Consumption 2018-2023 (K Units)
Figure Brazil Prostacyclin Value 2018-2023 ($ Millions)
Figure China Prostacyclin Consumption 2018-2023 (K Units)
Figure China Prostacyclin Value 2018-2023 ($ Millions)
Figure Japan Prostacyclin Consumption 2018-2023 (K Units)
Figure Japan Prostacyclin Value 2018-2023 ($ Millions)
Figure Korea Prostacyclin Consumption 2018-2023 (K Units)
Figure Korea Prostacyclin Value 2018-2023 ($ Millions)
Figure Southeast Asia Prostacyclin Consumption 2018-2023 (K Units)
Figure Southeast Asia Prostacyclin Value 2018-2023 ($ Millions)
Figure India Prostacyclin Consumption 2018-2023 (K Units)
Figure India Prostacyclin Value 2018-2023 ($ Millions)
Figure Australia Prostacyclin Consumption 2018-2023 (K Units)
Figure Australia Prostacyclin Value 2018-2023 ($ Millions)
Figure Germany Prostacyclin Consumption 2018-2023 (K Units)
Figure Germany Prostacyclin Value 2018-2023 ($ Millions)
Figure France Prostacyclin Consumption 2018-2023 (K Units)
Figure France Prostacyclin Value 2018-2023 ($ Millions)
Figure UK Prostacyclin Consumption 2018-2023 (K Units)
Figure UK Prostacyclin Value 2018-2023 ($ Millions)
Figure Italy Prostacyclin Consumption 2018-2023 (K Units)
Figure Italy Prostacyclin Value 2018-2023 ($ Millions)
Figure Russia Prostacyclin Consumption 2018-2023 (K Units)
Figure Russia Prostacyclin Value 2018-2023 ($ Millions)
Figure Spain Prostacyclin Consumption 2018-2023 (K Units)
Figure Spain Prostacyclin Value 2018-2023 ($ Millions)
Figure Egypt Prostacyclin Consumption 2018-2023 (K Units)
Figure Egypt Prostacyclin Value 2018-2023 ($ Millions)
Figure South Africa Prostacyclin Consumption 2018-2023 (K Units)
Figure South Africa Prostacyclin Value 2018-2023 ($ Millions)
Figure Israel Prostacyclin Consumption 2018-2023 (K Units)
Figure Israel Prostacyclin Value 2018-2023 ($ Millions)
Figure Turkey Prostacyclin Consumption 2018-2023 (K Units)
Figure Turkey Prostacyclin Value 2018-2023 ($ Millions)
Figure GCC Countries Prostacyclin Consumption 2018-2023 (K Units)
Figure GCC Countries Prostacyclin Value 2018-2023 ($ Millions)
Table Global Prostacyclin Consumption Forecast by Type (2018-2023) (K Units)
Table Global Prostacyclin Consumption Market Share Forecast by Type (2018-2023)
Table Global Prostacyclin Value Forecast by Type (2018-2023) ($ Millions)
Table Global Prostacyclin Value Market Share Forecast by Type (2018-2023)
Table Global Prostacyclin Consumption Forecast by Application (2018-2023) (K Units)
Table Global Prostacyclin Consumption Market Share Forecast by Application (2018-2023)
Table Global Prostacyclin Value Forecast by Application (2018-2023) ($ Millions)
Table Global Prostacyclin Value Market Share Forecast by Application (2018-2023)
Table United Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table United Therapeutics Prostacyclin Sales, Revenue, Price and Gross Margin (2016-2018)
Figure United Therapeutics Prostacyclin Market Share (2016-2018)
Table Actelion (J & J) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Actelion (J & J) Prostacyclin Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Actelion (J & J) Prostacyclin Market Share (2016-2018)
Table GSK Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GSK Prostacyclin Sales, Revenue, Price and Gross Margin (2016-2018)
Figure GSK Prostacyclin Market Share (2016-2018)
Table Teva Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Teva Prostacyclin Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Teva Prostacyclin Market Share (2016-2018)
Table Toray Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Toray Prostacyclin Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Toray Prostacyclin Market Share (2016-2018)
Table Tide Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Tide Pharma Prostacyclin Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Tide Pharma Prostacyclin Market Share (2016-2018)
Table Bayer AG Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer AG Prostacyclin Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Bayer AG Prostacyclin Market Share (2016-2018)


More Publications